Watch Tobi Guennel, Ph.D., QuartzBio’s Co-founder and Chief Technology Officer, demonstrate how a network of domain-specific AI agents, orchestrated by our first-in-class Virtual Assistant, empowers informatics, translational, and IT teams to conversationally explore and visualize clinical, sample, and biomarker data. The QuartzBio AI Agent network can perform tasks semi-autonomously based on expected events and observed data trends.
Join this webinar to learn how to use QuartzBio’s AI Agent Platform. You can ask questions, get answers, and gain insights at the speed of decision-making. Domain-specific AI agents, orchestrated by our Virtual Assistant, enable operations, translational, and informatics teams to conversationally interact with a connected ecosystem of biomarker, sample, and clinical data.
Watch the full episode: Tobi Guennel, PhD, SVP of Product Innovation at QuartzBio, joins AI expert Srivatsan Nagaraja to discuss his insights on integrating AI into the precision medicine value chain in an episode of the Life Sciences D’n’A Podcast. Tune in to learn about: Can’t see the video? Accept cookies to watch: Contact us […]
Clinical research and development starts with the sample data value chain. This value chain was the focus of an exciting session at the 2025 SCOPE Summit for Clinical Operations Executives. QuartzBio’s Tobi Guennel, PhD, inspired lively discussion in his presentation, “From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI.” He explored the opportunities for technology to empower the people and processes across the entire sample data value chain.
This month, we released version 10.0.0 of the QuartzBio Platform, delivering enhancements to the solutions for biomarker and sample intelligence, as well as the underlying Enterprise Data Platform, which supports data management activities.
Interoperability in R&D: What does it mean? In modern drug development, connectedness is crucial for success, especially in remote and decentralized teams. This connectedness involves linking people and information to extract shared insights from data and make faster decisions. In practice, this means ensuring interoperability of data, technology, systems, and ecosystems through a scalable, modular […]
QuartzBio is the only company purpose-built to deliver end-to-end Sample and Biomarker Intelligence for clinical-stage biopharma teams. Powered by a network of domain-specific AI agents, our solutions transform fragmented data into actionable intelligence, enabling conversational insights into your unified ecosystem of sample, clinical, and biomarker data.
QUARTZBIO® is a registered trademark of Precision Regulatory and Translational Sciences, Inc., dba QuartzBio, in the United States and/or other jurisdictions. All rights reserved.
© 2026 QuartzBio.
All rights reserved.
Privacy Policy | GDPR
